Insider Trading History of Coughlin Timothy

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Coughlin Timothy since 2008. This trader's CIK number is 1376043. At the time of last reporting, Coughlin Timothy was the Director of Atyr Pharma Inc. (stock ticker symbol LIFE). Also see all insider trading activities at Atyr Pharma Inc.

Note that in the past COUGHLIN TIMOTHY also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Coughlin Timothy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 FATE 0 $0 1,439 $32,823 0 $0
2016 FATE 56,390 $149,997 0 $0 0 $0

Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Coughlin Timothy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 NBIX 0 $0 5,963 $252,401 0 $0
2016 NBIX 0 $0 5,000 $216,234 0 $0
2015 NBIX 0 $0 178,500 $8,154,964 150,000 $515,300
2014 NBIX 0 $0 161,750 $3,095,879 50,000 $154,800
2013 NBIX 0 $0 30,000 $450,841 0 $0
2011 NBIX 0 $0 12,320 $84,108 0 $0
2010 NBIX 0 $0 21,347 $53,917 0 $0
2009 NBIX 0 $0 20,580 $70,184 0 $0
2008 NBIX 0 $0 7,857 $39,520 0 $0

Yearly summary of insider trading at Atyr Pharma Inc (LIFE) by Coughlin Timothy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 LIFE 0 $0 0 $0 6,000 $0


Insider trading activities at 3 companies by Coughlin Timothy:

1. Fate Therapeutics Inc (FATE)

2. Neurocrine Biosciences Inc (NBIX)

3. Atyr Pharma Inc (LIFE)

Table 1. Insider trading of Fate Therapeutics Inc (FATE) by Coughlin Timothy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-03 FATE Sale 1,439 22.81 32,823
2016-11-23 FATE Buy 56,390 2.66 149,997

Table 2. Insider trading of Neurocrine Biosciences Inc (NBIX) by Coughlin Timothy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-02-06 NBIX Sale 963 43.14 41,543
2017-02-03 NBIX Sale 1,500 42.55 63,824
2017-01-17 NBIX Sale 1,750 40.65 71,137
2017-01-10 NBIX Sale 1,750 43.37 75,897
2016-02-03 NBIX Sale 1,500 38.06 57,090
2016-01-19 NBIX Sale 1,750 46.69 81,707
2016-01-11 NBIX Sale 1,750 44.25 77,437
2015-10-16 NBIX Sale 25,000 47.78 1,194,500
2015-07-20 NBIX Option Ex 20,000 5.76 115,200
2015-07-20 NBIX Sale 20,000 55.00 1,100,000
2015-07-13 NBIX Option Ex 20,000 5.76 115,200
2015-07-13 NBIX Sale 20,000 50.00 1,000,000
2015-06-08 NBIX Sale 60,000 45.08 2,704,800
2015-06-08 NBIX Option Ex 60,000 2.59 155,400
2015-03-20 NBIX Option Ex 40,000 2.59 103,600
2015-03-20 NBIX Sale 40,000 44.49 1,779,600
2015-01-16 NBIX Sale 1,750 30.81 53,917
2015-01-12 NBIX Sale 1,750 28.37 49,647
2015-01-08 NBIX Option Ex 10,000 2.59 25,900
2015-01-08 NBIX Sale 10,000 27.25 272,500
2014-12-18 NBIX Sale 20,000 23.18 463,600
2014-12-19 NBIX Sale 10,000 24.02 240,200
2014-12-18 NBIX Option Ex 20,000 2.59 51,800
2014-12-19 NBIX Option Ex 10,000 2.59 25,900
2014-12-10 NBIX Sale 20,000 21.48 429,500
2014-12-10 NBIX Option Ex 20,000 3.85 77,100
2014-11-28 NBIX Sale 10,000 20.14 201,400
2014-10-31 NBIX Sale 10,000 19.00 190,000
2014-10-30 NBIX Sale 10,000 18.62 186,200
2014-10-28 NBIX Sale 10,000 18.00 180,000
2014-01-10 NBIX Sale 1,750 18.56 32,479
2014-01-07 NBIX Sale 70,000 16.75 1,172,500
2013-08-21 NBIX Sale 19,035 15.05 286,476
2013-08-05 NBIX Sale 10,965 14.99 164,365
2011-02-28 NBIX Sale 12,320 6.83 84,108
2010-03-01 NBIX Sale 12,650 2.53 31,966
2010-01-12 NBIX Sale 8,697 2.52 21,951
2009-03-30 NBIX Sale 12,117 3.43 41,537
2009-01-13 NBIX Sale 8,463 3.38 28,647
2008-02-12 NBIX Sale 7,857 5.03 39,520

Table 3. Insider trading of Atyr Pharma Inc (LIFE) by Coughlin Timothy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-26 LIFE Option Ex 6,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coughlin Timothy (Director of Atyr Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.